Back to Trades
THURMAN RANDY H
DirectorCIK: 0001204059
THURMAN RANDY H, Director, has filed 1 insider trading report covering 1 company. Total disclosed trading volume is $298.2K. Purchases and sales are approximately balanced over this period. The largest single filing involves Outlook Therapeutics, Inc. (OTLK). All transactions sourced from SEC Form 4 filings.
Total Volume
$298.2K
Purchases
$0
Sales
$0
Companies
1
Trading History (1 filings)
Other
$0